Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer
Jingying Nong, Yuhua Gong, Yanfang Guan, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 154

Showing 1-25 of 154 citing articles:

The emerging role of cell-free DNA as a molecular marker for cancer management
Abel J. Bronkhorst, Vida Ungerer, Stefan Holdenrieder
Biomolecular Detection and Quantification (2019) Vol. 17, pp. 100087-100087
Open Access | Times Cited: 486
Unravelling tumour heterogeneity by single-cell profiling of circulating tumour cells
Laura Keller, Klaus Pantel
Nature reviews. Cancer (2019) Vol. 19, Iss. 10, pp. 553-567
Closed Access | Times Cited: 463
TCR Repertoire Diversity of Peripheral PD-1+CD8+ T Cells Predicts Clinical Outcomes after Immunotherapy in Patients with Non–Small Cell Lung Cancer
Jiefei Han, Jianchun Duan, Hua Bai, et al.
Cancer Immunology Research (2019) Vol. 8, Iss. 1, pp. 146-154
Open Access | Times Cited: 217
Nucleic Acid Tests for Clinical Translation
Min Li, Fangfei Yin, Lu Song, et al.
Chemical Reviews (2021) Vol. 121, Iss. 17, pp. 10469-10558
Closed Access | Times Cited: 177
Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA)
R Chin, Kevin Chen, Abul Usmani, et al.
Molecular Diagnosis & Therapy (2019) Vol. 23, Iss. 3, pp. 311-331
Open Access | Times Cited: 153
Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer
Jian Yang, Yuhua Gong, Vincent K. Lam, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 5
Open Access | Times Cited: 148
Current and Future Clinical Applications of ctDNA in Immuno-Oncology
Julia-Christina Stadler, Yassine Belloum, Benjamin Deitert, et al.
Cancer Research (2021) Vol. 82, Iss. 3, pp. 349-358
Open Access | Times Cited: 108
The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer
J.E. Berchuck, Francesco Facchinetti, Daniel DiToro, et al.
Annals of Oncology (2022) Vol. 33, Iss. 12, pp. 1269-1283
Open Access | Times Cited: 82
Concurrent Tissue and Circulating Tumor DNA Molecular Profiling to Detect Guideline-Based Targeted Mutations in a Multicancer Cohort
Wade T. Iams, Matthew MacKay, Rotem Ben‐Shachar, et al.
JAMA Network Open (2024) Vol. 7, Iss. 1, pp. e2351700-e2351700
Open Access | Times Cited: 28
Emerging advances in defining the molecular and therapeutic landscape of small-cell lung cancer
Triparna Sen, Nobuyuki Takahashi, Subhamoy Chakraborty, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 8, pp. 610-627
Closed Access | Times Cited: 24
Nucleic Acids Analysis
Yongxi Zhao, Xiaolei Zuo, Qian Li, et al.
Science China Chemistry (2020) Vol. 64, Iss. 2, pp. 171-203
Open Access | Times Cited: 118
Circulating tumor DNA analyses predict progressive disease and indicate trastuzumab-resistant mechanism in advanced gastric cancer
Yan Wang, Chuanhua Zhao, Lianpeng Chang, et al.
EBioMedicine (2019) Vol. 43, pp. 261-269
Open Access | Times Cited: 80
Circulating Tumor DNA in Precision Oncology and Its Applications in Colorectal Cancer
Maria F. Arisi, Efrat Dotan, Sandra V. Fernandez
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4441-4441
Open Access | Times Cited: 49
Molecular subtyping of small cell lung cancer
Jie Liang, Xiaojiao Guan, Guangyao Bao, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 450-462
Closed Access | Times Cited: 39
Dynamics of Sequence and Structural Cell-Free DNA Landscapes in Small-Cell Lung Cancer
Lavanya Sivapalan, Wade T. Iams, Zineb Belcaid, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 12, pp. 2310-2323
Open Access | Times Cited: 30
Small Cell Lung Carcinoma: Current Diagnosis, Biomarkers, and Treatment Options with Future Perspectives
Kristina Krpina, Semir Vranić, Krešimir Tomić, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 1982-1982
Open Access | Times Cited: 23
Predictive biomarkers for immunotherapy response in extensive-stage SCLC
Lin Zhu, Jing Qin
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 1
Open Access | Times Cited: 14
Correlation between rs1800871, rs1800872 and rs1800896 Polymorphisms at IL-10 Gene and Lung Cancer Risk
Mohammad Rahim Vakili, Ahmad Shirinzadeh-Dastgiri, Reza Ershadi, et al.
Asian Pacific Journal of Cancer Prevention (2024) Vol. 25, Iss. 1, pp. 287-298
Open Access | Times Cited: 9
Tissue and circulating biomarkers of benefit to immunotherapy in extensive-stage small cell lung cancer patients
M. Lorenzi, M.V. Resi, Laura Bonanno, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
Recent Advances in the Clinical Translation of Small-Cell Lung Cancer Therapeutics
Subhadeep Das, Shayak Samaddar
Cancers (2025) Vol. 17, Iss. 2, pp. 255-255
Open Access | Times Cited: 1
Profiling of Circulating Free DNA Using Targeted and Genome-wide Sequencing in Patients with SCLC
Sumitra Mohan, Victoria Foy, Mahmood Ayub, et al.
Journal of Thoracic Oncology (2019) Vol. 15, Iss. 2, pp. 216-230
Open Access | Times Cited: 68
Notch pathway in small-cell lung cancer: from preclinical evidence to therapeutic challenges
Alessandro Leonetti, Francesco Facchinetti, Roberta Minari, et al.
Cellular Oncology (2019) Vol. 42, Iss. 3, pp. 261-273
Closed Access | Times Cited: 66
Epigenetic silencing of chemokine CCL2 represses macrophage infiltration to potentiate tumor development in small cell lung cancer
Yang Zheng, Zhihong Wang, Simeng Wei, et al.
Cancer Letters (2020) Vol. 499, pp. 148-163
Closed Access | Times Cited: 66
Liquid biopsy tracking of lung tumor evolutions over time
Alessandro Russo, Diego Pérez, Muthukumar Gunasekaran, et al.
Expert Review of Molecular Diagnostics (2019) Vol. 19, Iss. 12, pp. 1099-1108
Closed Access | Times Cited: 59
Circulating Tumor DNA Predicts the Response and Prognosis in Patients With Early Breast Cancer Receiving Neoadjuvant Chemotherapy
Shunying Li, Hongna Lai, Jieqiong Liu, et al.
JCO Precision Oncology (2020), Iss. 4, pp. 244-257
Open Access | Times Cited: 58
Page 1 - Next Page

Scroll to top